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Abstract
The role of human choroid plexus (CP) epithelium in the transport of solutes between the blood and the
cerebrospinal fluid and/or in secretion processes may be studied by employing several experimental approaches.
There are a number of in vitro techniques for human CP epithelium (CPE) and all have limitations that do not
exclude them a priori, but that should be carefully taken into consideration. Developmental and morphological
studies have been largely performed on human choroid plexus samples of either embryonic or post-mortem origin.
Functional uptake studies may be performed on pathologically unaltered CP samples obtained during surgical
removal of choroid plexus tumors. This approach can be used to explore transport processes mainly across the
apical side of the CPE, but cannot be used to study vectorial transport across the CPE. Also, these samples have
limited viability. A monolayer of CPE in culture, grown on permeable supports, provides the best available tool to
study transport processes or polarized secretion by the CP, but thus far only limited attempts to culture these cells
have been published and they mainly include data from neoplastic CPE. A study that used a human
papilloma-derived cell line in culture showed that it forms a monolayer with barrier properties, although the cells
express pleomorphic and neoplastic features and lack contact inhibition. Other cell cultures express some CPE
markers but do not develop tight junctions/barrier properties. This article reviews the main characteristics and
limitations of available in vitro methods to study human CPE, which could help researchers choose an appropriate
experimental approach for a particular study.
Keywords: Human choroid plexus, Cerebrospinal fluid, Blood-cerebrospinal fluid barrier, Choroid plexus papilloma,
Choroid plexus carcinoma, Primary culture, Choroid plexus epithelium
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Introduction
A constant and well-controlled composition of extracellular
fluid in the central nervous system (CNS) is essential for
neuronal processing. Thus, all existing vertebrates have
cellular structures that provide efficient physical separation
of the circulating plasma from brain extracellular fluids [1].
The two most important are the endothelial blood–brain
barrier (BBB) which separates plasma from the interstitial
fluid of the brain, and the epithelial blood-cerebrospinal
fluid barrier (BCSFB), which separates blood from ventricu-
lar cerebrospinal fluid (CSF). These cellular structures
impede free paracellular diffusion of hydrophilic solutes
and transcellular diffusion of lipophilic compounds from
circulating plasma into extracellular fluids of the brain and
exclude xenobiotics, providing the controlled environment
required for optimal CNS function.
The BCSFB is formed by the epithelium of the choroid
plexuses (CPs). The BCSFB has a considerable surface
area for exchange between the blood and the CSF
through the presence of microvilli on the apical surface
and interdigitations on the basolateral surface. The
barrier phenotype of this cellular interface is achieved
mainly by continuous tight junctions (TJs) between adja-
cent cells of the CP epithelium (CPE). These intercellu-
lar structures greatly limit paracellular diffusion and,
thus, exchange of polar solutes between the blood and
the CSF [2]. Claudins 1, 2, 3 and 11 are the most import-
ant members of the claudin family of TJ proteins of the
CPE [3]. Claudin 11 in the TJs of the CPE is responsible
for parallel-stranded TJs, observed in freeze-fracture
morphology [3,4]. This relationship between structure
and molecular composition of the TJs is important and
could be used as an indicator of whether or not the CPE
maintains functional features in vitro. Together with
restriction of free paracellular diffusion, the presence of
a large number of transport systems and intracellular
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metabolic activities contribute significantly to the barrier
properties of the BCSFB [5]. Many transport systems
and ion transporters and channels have an unequal
distribution between the basolateral membrane, that
faces CP interstitial fluid, and the apical membrane, that
faces ventricular CSF. These polarized transport and
secretion processes in the CPE are essential for secretion
of ventricular CSF.
Several experimental approaches have been used to
explore functions of the human CPs. Human CSF
samples are frequently taken for diagnostic purposes and
are used mainly for detection of biomarkers for develop-
mental disorders or for various CNS pathologies, including
neuroinflammatory and neurodegenerative diseases [6,7].
However, it is difficult to explore functions of the human
CPE by analysis of blood plasma and CSF samples because
the CSF is constantly renewed in vivo and diffusion of
solutes from the brain interstitial fluid into the CSF
influences the CSF composition.
The most accessible human CP samples were those
that were either taken from aborted embryos or from
post-mortem adult brains. Human embryonic CP
samples have been used to analyze the expression of
transport proteins that are important for the CP
function, for instance, ATP-binding cassette transporters
ABCB1, ABCB4, ABCC1 [8], or to explore developmental
changes in CP morphology and protein expression [9].
Samples taken post-mortem have been used to explore
expression of various proteins in the human CP; for
example, the expression of hepatocyte nuclear factor 4
(HNF4-alpha), a transcription factor that targets numer-
ous drug-metabolizing enzymes and drug transporters
important for the detoxifying function of the CPs, has
been explored in detail in CP samples from adult brains
[10]. Although post-mortem samples could not be used
for functional studies, mapping protein expression in
human CP taken post-mortem can be used to predict
function. For example, it has been shown that the water
channel, aquaporin-1, Na+-K+-ATPase α1-subunit and
Na+-K+-2Cl− cotransporter are localized apically in the
human choroid plexus epithelial cells; the Cl−/HCO3
−
exchanger, AE2, is localized basolaterally, as is the
Na+-dependent Cl−/HCO3
− exchanger, NCBE, and the
electroneutral Na+-HCO3
− cotransporter, NBCn1. No
immunoreactivity was found for the Na+-dependent acid/
base transporters NHE1 or NBCe2 [11]. Since this pattern
of distribution is very similar to that observed in other spe-
cies, such as rat or mouse, authors have concluded that the
preserved pattern of expression across species suggests cen-
tral roles for these transporters in CSF production [11].
The main limitation of this approach is that the CP samples
can only be collected after several hours have elapsed and
may be taken more than 1 day post-mortem; this delay in
tissue processing could affect protein content in the CPE
due to proteolysis [12]. An alternative approach would be
to obtain human CP samples after neurosurgery and to use
them immediately for molecular biology or for functional
uptake studies or to produce a cell culture of human CPE.
These approaches have several advantages and limitations
that will be briefly reviewed in this article.
Functional studies on human CP samples
Human CP samples may be obtained as spare material
from neurosurgery. In most cases, a small amount of
healthy CP tissue has to be dissected during surgical
removal of a large choroid plexus papilloma. An import-
ant first step is to examine samples in order to separate
pathologically-unaltered tissue which can be used either
for uptake studies, immunocytochemistry or for molecular
biology. Uptake studies can be performed with two
radiotracers: a test molecule and a reference molecule
which serves as an extracellular space marker. The latter is
usually radiolabelled mannitol or sucrose or a larger
extracellular space marker like inulin, the choice depending
on the size and physical properties of the test molecule.
The total amount of test molecule that is found in the
tissue sample after the incubation consists of two different
pools: a) test molecules that diffuse from aCSF into the CP
extracellular fluid (ECF) and remain in the ECF; b) test
molecules that entered the CPE during the course of the
experiment, a process mediated by some of the equilibrative
or concentrative transporters at the plasma membranes of
the CP cells. It is not possible to estimate amounts of a test
molecule in these two pools directly. However, the
reference molecule, if properly selected, behaves similarly
to the test molecule during the course of experiment, with
the only difference being that it cannot be taken up by the
cells, because of the absence of specific transport systems
to mediate cellular entry. Thus, the amount of the test
molecule in the ECF can be estimated by determining the
reference molecule radioactivity / mg tissue protein. More
accurate data are obtained if the reference molecule radio-
activity is multiplied by the reference molecule DPM / test
molecule DPM ratio in the sample. This approach was used
to characterize nucleoside transport across the apical side
of human CPE [13].
However, there are three factors that should be taken
into account when considering this experimental tech-
nique. First, the basolateral (CP interstitial fluid)-facing
side of the CPE is not easily accessible during these
experiments because under the experimental conditions,
no perfusion pressure is present in the microcirculation,
a situation which could cause CP capillaries to collapse.
Bearing in mind the histological structure of the CP
[14], the diffusion of solutes from the aCSF into the CP
interstitial fluid under these circumstances would be
rather limited. Furthermore, the existence of TJs between
epithelial cells of the CP occludes the paracellular space
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and further impedes diffusion of solutes from the aCSF
into the CP interstitial fluid that surrounds the basolateral
membrane [14]. Taking into account the importance of
vectorial transport across the CPE, data obtained by this
type of study have limited applicability. Second, the
prospective duration of a single experiment is constrained
by the limited viability of isolated CP samples. Third, a
contribution of other cell types to the experimental data
(e.g. to the rate of uptake or to the amount of mRNA or
protein) cannot be excluded.
In vitro cell cultures of human CPE
In order to study vectorial transport of solutes across
the CPE or CSF secretion, samples of human CP could
be used to produce an in vitro cellular model of the
BCSFB. Several attempts have been made to produce cell
cultures using either fetal CP or CP tumors. Samples of
human CPs or CP tumors were used either as tissue
explants, which were sources of epithelial cells with
preserved viability, or to obtain single epithelial cells and
epithelial cell clusters after the digestion with dispase,
pronase or diluted trypsin (for more details on digestion of
CP samples see [15]). Cells are then plated onto transwell
permeable supports or into tissue culture plates.
Early attempts to culture human CPE date from 1949,
when the first report of fetal human CP cells in tissue
culture was published [16]. This early study used CPs
from human fetuses of different gestational ages
(crown-rump length measuring from 52–160 mm) and
maintained them as tissue explants in rolling test tubes
in a nutrient medium consisting of Tyrode solution,
Locke-Lewis solution, human placental serum and
chick embryo extract [16]. Epithelial cells migrated
from these explants, forming islands (“plates”) or ribbons
of cells that curved and branched [16]. An attempt was
also made to culture adult brain cells, including CPE, from
brain tissue that was taken either during biopsy or 6-24 h
post-mortem; this tissue was maintained either as explants
or was digested to single cells that were plated into culture
plates [17]. Under these conditions, monolayers of CPE
were established in less than one week and CPE growth
was faster than from brain parenchyma [17]. CP cells from
explants grew as bipolar spindle-shaped cells in an orderly
fashion [18]. This culture was also used to explore the
mechanism of cytomegalovirus infection and growth [19].
However, use of primary human CPE cell culture with
either an embryonic or post-mortem/biopsy origin was
gradually abandoned over the time. Possibly, the main
reason for this was difficulty in obtaining well-preserved
samples frequently enough to produce sufficient material
for primary cultures. Also, tissue samples often produce
a rather limited amount of primary cells with variability
between different cultures that is often large, and which
could be due to the variable times needed to obtain the
tissue post-mortem. To overcome this problem, several
cell lines were generated from neoplastic human CPE.
Human choroid plexus papilloma cell line (HIBCPP)
A choroid plexus papilloma is a tumor of a CPE origin
occurring in cerebral ventricles, which is infrequently
malignant [20]. Using malignant papilloma from a 29-year
old woman, a research group in Japan established a malig-
nant cell line [21]. This was achieved by the digestion of the
tumor tissue in dispase, followed by incubation of the digest
at 37°C in 5% CO2 and air on uncoated and untreated
cell culture plastics in Ham’s F-12 medium supplemented
with 10% fetal calf serum (FCS) and antibiotics [21]. It
was initially reported that these cells demonstrated
pleomorphic and neoplastic features and lacked contact
inhibition [21]. Thus, they formed heterogeneous multi-
layers [21]. For these reasons it was believed that this
cell line was unlikely to be suitable for use as an in vitro
model of the BCSFB [15].
However, a recent report [22] has revealed that, if
growth conditions are carefully optimized, with seeding
density adjustment and selective trypsinization, these
cells can develop some features of the CPE in situ,
including increase in transepithelial electrical resistance
[TEER] up to 500 Ω cm2, low paracellular diffusion of a
paracellular marker FITC-labelled inulin, formation of the
TJs between adjacent cells that were located close to the
apical border (Figure 1) and the presence of microvilli [22].
To achieve these characteristics, HIBCPP cells were
cultured in DMEM/HAM’s F12 medium that was
supplemented with 15% FCS, L-glutamine and insulin
and were seeded on transwell filters with 3.0 μm pore
size, although 0.45 μm pore size could also be used [22].
HIBCPP cells were introduced either as the standard
transwell filter system, with cells seeded on the upper
side of the filter, or as the inverted transwell filter
system, with cells seeded on the lower side of the filter
(with the apical side of the cells facing the bottom of the
well, Figure 2), the latter system being originally developed
to study bacterial invasion across the CPE in vitro [23] and
has also been used recently to study the permissiveness of
human CPE for Echovirus 30 and T cell migration across
the CPE layer [24].
HIBCPP cells reached optical confluence 3–4 days
after seeding. At this point, cell density was ≈1.2 million
cells / cm2 and the TEER started to rise, reaching several
hundred Ω cm2 after a week [22]. This could be a conse-
quence of the formation of TJs between adjacent cells,
resembling the in situ structure of the CPE (Figure 1).
However, as shown in Figure 1C and D, TJs displayed
densely meshed strands, rather than a parallel-stranded
appearance, which could indicate absence or dislocation
of claudin 11. The TEER value in this culture appears to
be strongly related to the amount of FCS in the medium
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from day 3–4 after seeding onwards, with cultures that
were incubated with less FCS having higher TEERs.
These cells expressed several proteins at the transcript
level that are typical for the CPE, such as transthyretin
and insulin-like growth factor 2.
However, the characteristics of this culture should be
carefully considered for every study. First, by being
derived from anaplastic CPE, this cell line is likely to
show considerable differences in protein expression and
cellular metabolism, when compared to pathologically-
unaltered human CPE in vivo. Second, HIBCPP cells
were used after more than 30 passages, a fact that is
likely to further contribute to dedifferentiation of these
cells. Third, their morphology appears to be rather
different from the morphology of the CPE primary
cultures: cells differed in size and did not display a
typical “cobblestone-like” appearance of the CPE in
primary cultures. Also, these cells possessed very large
Figure 1 Tight junctions (TJ) in human malignant choroid plexus papilloma cell line (HIBCPP) grown on transwell filter supports in the
standard (A, C) and the inverted (B, D) culture system, respectively. Transmission electron microscopy (A, B) shows that in both culture
systems the cells are connected by TJs (arrows), which are located close to the apical side as indicated by the presence of microvilli. Examination
of HIBCPP by freeze fracture electron microscopy (C, D) revealed a broad band of closely meshed TJ strands. The diameter of mesh was in the
magnitude of 0.2 to 0.4 μm. Reproduced with permission from the author [22].
Figure 2 Schematic representation of standard and inverted transwell filter systems. Most studies that explored vectorial processes across
the CPE have used a standard transwell filter system. The inverted system was originally developed to analyze bacterial invasion and translocation
in a porcine CPE in culture [23] and it enabled studies of bacterial interaction with the basolateral (blood) side of the CPE. Reproduced with
permission from the author [22].
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nuclei that in some cases almost filled the cells [22].
Fourth, HIBCPP cells often do not show contact inhibition
and, thus, have a tendency to grow in multiple layers [21].
Thus, as described above, a careful adjustment of seeding
density and selective trypsinization has to be applied in
order obtain a cellular monolayer. Fifth, these cells change
both doubling time and plating efficiency with increasing
passages [21]. However, if all these factors are taken fully
into consideration, this cell culture could be used as a
proper tool, similar to the case of studies that explored
bacterial and translocation and T cells migration across the
human CPE [22,24].
There was another reported attempt to cultivate cells
derived from a fragment of a fourth-ventricle CP papilloma;
these were shown to form a monolayer with a pavement-
like appearance and displayed ultrastructural features simi-
lar to those of the papilloma epithelial cells [25]. However,
no further data could be found about this cell culture.
Human choroid plexus carcinoma cell line
Another human CPE cell line, CPC-2, was initially
produced from a CPE carcinoma taken from a 2-month old
boy, which is a rare tumor [26]. The tissue was mechanic-
ally dissociated and enzymatically digested after neurosur-
gery, then passed through a 70 μm strainer and cultured in
Dulbecco’s minimum essential medium supplemented with
20% FCS under conventional culture conditions [26].
These cells have been used for several studies. Usually,
cells were seeded at a density of 104 cells/cm2 (Dr. Joanna
Szmydynger-Chodobska, Brown University, USA, personal
communication) on collagen-1 coated plastic in high-
glucose DMEM supplemented with 10% FCS. These
cells are slow-growing; their doubling time is 7–10 days
(Dr. Joanna Szmydynger-Chodobska, personal commu-
nication); depending on initial seeding density, it may
take 2–3 weeks for them to reach 90% confluence.
They form monolayers that are less regular and consist
of larger cells, when compared to CPE cultures of
animal origin [27]. They expressed TJ proteins, occludin
and claudin-1. Although occludin immunoreactivity was
mainly restricted to the TJ areas, claudin 1 was found to be
restricted to the nuclei of these epithelial cells (Figure 3).
Overall, the staining patterns for these proteins were often
irregular. Under phase-contrast microscopy, they often did
not show a typical cobblestone-like appearance. Thus, it is
unlikely that this cell line could be used to explore the
barrier properties of the CPE. However, CPC-2 cells
produce endothelin 1 [28] and adrenomedullin [29],
which are characteristics of the CPE in situ.
Human choroid plexus epithelium primary culture
Recently, human choroid plexus epithelial cells became
commercially available from ScienCell laboratories
(Carlsbad, CA, USA). These are offered in batches of
50,000 cells in a ready-to-use seeding medium; the
manufacturer guarantees the ability to further expand
for 15 population doublings under specific conditions. It
is recommended to seed these cells on poly-L-lysine
treated plastic, without specific coating with basal
lamina proteins, with a seeding density of 5,000 cells/cm2.
Cells should be left undisturbed for at least 16 hours, then
Epithelial Cell Medium supplemented with 10% FCS,
antibiotics, epidermal growth factor and insulin should be
added; all of these reagents are available from the supplier
of this cell line. However, in some studies, these cells were
grown successfully in the medium that included 2% FCS
[30]. When cells attach they display polygonal shaped
sheets of neighboring cells. The doubling time is 48-72 h.
Cells were positive for the epithelial markers cytokeratin-18,
-19 and vimentin. Once cells in culture reach 90% conflu-
ence, they should be passaged to poly-L-lysine treated plastic
(either wells or filters) with the same seeding density. These
cells could be passaged up to 15 times, however, some re-
search groups limit their use to 1–4 passages [30], because
some of their features change in later passages.
These cells were successfully used in studies that did
not require barrier properties of the cellular monolayer:
to explore the importance of epithelial V-like antigen in
adhesion of CD4+ T lymphocytes to human choroid
plexus epithelial cells in vitro [30]; to reveal the expression
profile of esophageal cancer-related gene-4 in human CP
Figure 3 Immunocytochemical analysis of expression of
junctional proteins in CPC-2 cell line derived from human CP
carcinoma. This image shows that CPC-2 cells expressed TJ
proteins, occludin and claudin-1 and adherent junctions proteins
E-cadherin and β-catenin. Occludin and β-catenin immunoreactivity
was largely restricted to the cell-to-cell contact areas, while claudin 1
was found to be restricted to the nuclei of these epithelial cells.
Expression of E-cadherin was slim, but largely restricted to cell-to-cell
contacts. These findings could be caused by dedifferentiation of
CPC-2 cells, when compared to pathologically unaltered CPE. Scale
bar = 10 μm. Reproduced with permission from the author [27].
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[31] and to explore cellular uptake (rather than transen-
dothelial transfer) of glutaric acid [32]. However, there are
several unresolved issues regarding these cells: first, it is
not clear what was their origin - whether it was human
CPE taken post-mortem or CPs from fetuses after
abortions; attempts to obtain this information from the
manufacturer were unsuccessful. Second, it was suggested
by the manufacturer that hCPE primary cells could be
passaged up to 15 times. Taking into account that other
primary CPE cell lines have a rather limited life span and
that a dedifferentiation and fibroblast contamination is
obvious even after 1–2 passages, as in the case of primary
cultures of rat [33] or sheep [34] CPE, this raises a
concern regarding whether these cells are primary in their
nature. Third, images that are provided by the manu-
facturer (available at http://www.sciencellonline.com/site/
productInformation.php?keyword=1310) do not reveal a
typical “cobblestone” -like appearance, a hallmark of
differentiated epithelial cells in culture.
Conclusions
Studies on human CP have been performed either on
samples taken post-mortem or after neurosurgery, or on
cell cultures. Currently, no evidence exists which
indicates that a primary or immortalized cell culture of
pathologically unaltered human CPE is available. Most
studies on human CPE in culture have in fact been
performed on malignant CPE, with rather advanced
anaplastic features. Thus, a careful interpretation of
acquired data is essential for achieving the correct
conclusions, since it is clear that findings obtained from
these cell cultures cannot be directly extrapolated to the
in vivo situation. However, emerging data from the
HIBCPP cell line indicate that it could be used to produce
monolayers that display some the barrier properties, thus
this neoplastic cell line might be used to explore transport
and other vectorial processes across the CPE. Other avail-
able CP cultures could be used to explore processes that
do not require the presentation of barrier function. Thus,
it appears that studies on human CPE in culture will be
successful if the characteristics of a particular cell culture
are considered carefully against the aims of the particular
study. At the end, a question arises whether studies on
human CPE are essential to explore human CP function,
or data from animal studies could be extrapolated to
humans. With the data published so far, it appears to be
rather difficult to give a simple answer to this question
and it probably largely depends on the process studied. In
example, as mentioned above, it has been shown that the
pattern of distribution of aquaporin-1, Na+-K+-ATPase
α1-subunit and Na+-K+-2Cl− cotransporter in human CPE
were very similar to that observed in rat or mouse [11],
indicating essential role of these proteins in CSF secretion,
which is a fundamental CP function. On the other hand,
an in vitro study on human CP samples taken during
neurosurgery has indicated that nucleoside uptake by the
apical CSF facing side of the CPE was most likely mediated
by both human equilibrative nucleoside transporter 2 and
human concentrative nucleoside transporter 3 and
transcript for the latter transporter was abundant [14],
while in the rat CPE in primary culture rat concentrative
nucleoside transporter 3 transcript was absent [35], which
could indicate differences in roles of CPs in humans and
rat in nucleoside homeostasis in the brain.
Abbreviations
ABCB1: ATP-binding cassette sub-family B member 1, also known as P-
glycoprotein; ABCB4: ATP-binding cassette, sub-family B, member 4, also
known as MDR3; ABCC1: Multidrug resistance-associated protein 1;
BCSFB: Blood-cerebrospinal fluid barriers; CP: Choroid plexus; CPC: CP
carcinoma; CPE: CP epithelium; CRL: Crown-rump length; CSF: Cerebrospinal
fluid; DMEM: Dulbecco’s Modified Eagle Medium; ECF: Extracellular fluid;
FCS: Fetal calf serum; HBSS: Hank’s Buffered Salt Solution; hCNTs: Human
concentrative nucleoside transporters; hENTs: Human equilibrative
nucleoside transporters; HIBCPP: Human malignant choroid plexus papilloma
cell line; TEER: Transendothelial electrical resistance; TJ: Tight junctions.
Competing interests
The author declares that he has no competing interests.
Authors’ contributions
ZR - sole author. The author has read and approved the final version of the
manuscript.
Acknowledgements
The author acknowledges help of Dr. Gina Hadley, University of Oxford, in
improving style and clarity of the manuscript.
Received: 1 October 2012 Accepted: 22 January 2013
Published: 7 February 2013
References
1. Bundgaard M, Abbott NJ: All vertebrates started out with a glial blood–brain
barrier 4–500 million years ago. Glia 2008, 56:699–708.
2. Anderson JM, Van Itallie CM: Physiology and function of the tight
junction. Cold Spring Harb Perspect Biol 2009, 1:a002584.
3. Wolburg H, Paulus W: Choroid plexus: biology and pathology. Acta
Neuropathol 2010, 119:75–88.
4. Dermietzel R, Meller K, Tetzlaff W, Waelsch M: In vivo and in vitro formation
of the junctional complex in choroid epithelium. A freeze-etching study.
Cell Tissue Res 1977, 181:427–441.
5. Redzic Z: Molecular biology of the blood–brain and the blood-cerebrospinal
fluid barriers: similarities and differences. Fluids Barriers CNS 2011, 8:3.
6. Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS: Proteomics of human
cerebrospinal fluid: discovery and verification of biomarker candidates in
neurodegenerative diseases using quantitative proteomics. J Proteomics
2011, 74:371–388.
7. Hwang HJ, Quinn T, Zhang J: Identification of glycoproteins in human
cerebrospinal fluid. Methods Mol Biol 2009, 566:263–276.
8. Greenwood S, Swetloff A, Wade AM, Terasaki T, Ferretti P: Fgf2 is expressed
in human and murine embryonic choroid plexus and affects choroid
plexus epithelial cell behaviour. Cerebrospinal Fluid Res 2008, 5:20.
9. Swetloff A, Ferretti P: Changes in E2F5 intracellular localization in mouse
and human choroid plexus epithelium with development. Int J Dev Biol
2005, 49:859–865.
10. Niehof M, Borlak J: Expression of HNF4alpha in the human and rat choroid
plexus: implications for drug transport across the blood-cerebrospinal-fluid
barrier. BMC Mol Biol 2009, 10:68.
11. Praetorius J, Nielsen S: Distribution of sodium transporters and
aquaporin-1 in the human choroid plexus. Am J Physiol Cell Physiol 2006,
291:C59–67.
Redzic Fluids and Barriers of the CNS 2013, 10:10 Page 6 of 7
http://www.fluidsbarrierscns.com/content/10/1/10
12. Madea B, Musshoff F: Postmortem biochemistry. Forensic Sci Int 2007,
165:165–171.
13. Redzic ZB, Malatiali SA, Grujicic D, Isakovic AJ: Expression and functional
activity of nucleoside transporters in human choroid plexus.
Cerebrospinal Fluid Res 2010, 7:2.
14. Johanson CE, Stopa EG, McMillan PN: The blood-cerebrospinal fluid
barrier: structure and functional significance. Methods Mol Biol 2011,
686:101–103.
15. Strazielle N, Ghersi-Egea JF: In Vitro Models of the Blood–Cerebrospinal Fluid
Barrier and Their Use in Neurotoxicological Research. Neuro Methods
2011, 56:161–184.
16. Hogue MJ: Human fetal choroid plexus cells in tissue cultures. Anat Rec
1949, 103:381–399.
17. Gilden DH, Devlin M, Wroblewska Z, Friedman H, Balian Rorke L, Santoli D,
Koprowski H: Human brain in tissue culture. I. Acquisition, initial
processing, and establishment of brain cell cultures. J Comp Neurol 1975,
161:295–306.
18. Wroblewska Z, Devlin M, Gilden DH, Santoli D, Friedman H, Koprowski H:
Human brain in tissue culture. II. Studies of long-term cultures. J Comp
Neurol 1975, 161:307–316.
19. Wroblewska Z, Wellish MC, Wolinsky JS, Gilden D: Comparison of human
cytomegalovirus growth in MRC-5 human fibroblasts, brain, and choroid
plexus cells in vitro. J Med Virol 1981, 8:245–256.
20. Addo NK, Kamaly-Asl ID, Josan VA, Kelsey AM, Estlin EJ: Preoperative
vincristine for an inoperable choroid plexus papilloma: a case discussion
and review of the literature. J Neurosurg Pediatr 2011, 8:149–153.
21. Ishiwata I, Ishiwata C, Ishiwata E, Sato Y, Kiguchi K, Tachibana T, Hashimoto
H, Ishikawa H: Establishment and characterization of a human malignant
choroids plexus papilloma cell line (HIBCPP). Hum Cell 2005, 18:67–72.
22. Schwerk C, Papandreou T, Schuhmann D, Nickol L, Borkowski J, Steinmann
U, Quednau N, Stump C, Weiss C, Berger J, Wolburg H, Claus H, Vogel U,
Ishikawa H, Tenenbaum T, Schroten H: Polar invasion and translocation of
Neisseria meningitidis and Streptococcus suis in a novel human model
of the blood-cerebrospinal fluid barrier. PLoS One 2012, 7(1):e30069.
23. Tenenbaum T, Papandreou T, Gellrich D, Friedrichs U, Seibt A, Adam R,
Wewer C, Galla HJ, Schwerk C, Schroten H: Polar bacterial invasion and
translocation of Streptococcus suis across the blood-cerebrospinal fluid
barrier in vitro. Cell Microbiol 2009, 11:323–336.
24. Schneider H, Weber CE, Schoeller J, Steinmann U, Borkowski J, Ishikawa H,
Findeisen P, Adams O, Doerries R, Schwerk C, Schroten H, Tenenbaum T:
Chemotaxis of T-cells after infection of human choroid plexus papilloma
cells with Echovirus 30 in an in vitro model of the blood-cerebrospinal
fluid barrier. Virus Res 2012, 170:66–74.
25. Nakashima N, Goto K, Tsukidate K, Sobue M, Toida M, Takeuchi J: Choroid
plexus papilloma. Light and electron microscopic study. Virchows Arch A
1983, 400:201–11.
26. Kumabe T, Tominaga T, Kondo T, Yoshimoto T, Kayama T: Intraoperative
radiation therapy and chemotherapy for huge choroid plexus carcinoma
in an infant: case report. Neurol Med Chir (Tokyo) 1996, 36:179–184.
27. Szmydynger-Chodobska J, Pascale CL, Pfeffer AN, Coulter C, Chodobski A:
Expression of junctional proteins in choroid plexus epithelial cell lines: a
comparative study. Cerebrospinal Fluid Res 2007, 4:11.
28. Takahashi K, Hara E, Murakami O, Totsune K, Sone M, Satoh F, Kumabe T,
Tominaga T, Kayama T, Yoshimoto T, Shibahara S: Production and
secretion of endothelin-1 by cultured choroid plexus carcinoma cells.
Cardiovasc Pharmacol 1998, 31(Suppl 1):S367–369.
29. Takahashi K, Satoh F, Hara E, Murakami O, Kumabe T, Tominaga T, Kayama T,
Yoshimoto T, Shibahara S: Production and secretion of adrenomedullin by
cultured choroid plexus carcinoma cells. J Neurochem 1997, 68:726–731.
30. Wojcik E, Carrithers LM, Carrithers MD: Characterization of epithelial V-like
antigen in human choroid plexus epithelial cells: potential role in CNS
immune surveillance. Neurosci Lett 2011, 495:115–120.
31. Gonzalez AM, Podvin S, Lin SY, Miller MC, Botfield H, Leadbeater WE,
Roberton A, Dang X, Knowling SE, Cardenas-Galindo E, Donahue JE, Stopa
EG, Johanson CE, Coimbra R, Eliceiri BP, Baird A: Ecrg4 expression and its
product augurin in the choroid plexus: impact on fetal brain
development, cerebrospinal fluid homeostasis and neuroprogenitor cell
response to CNS injury. Fluids Barriers CNS 2011, 8:6.
32. Sauer SW, Opp S, Mahringer A, Kamiński MM, Thiel C, Okun JG, Fricker G,
Morath MA, Kölker S: Glutaric aciduria type I and methylmalonic aciduria:
simulation of cerebral import and export of accumulating neurotoxic
dicarboxylic acids in in vitro models of the blood–brain barrier and the
choroid plexus. Biochim Biophys Acta 2010, 1802:552–560.
33. Strazielle N, Ghersi-Egea JF: Demonstration of a coupled metabolism-
efflux process at the choroid plexus as a mechanism of brain protection
toward xenobiotics. J Neurosci 1999, 19:6275–6289.
34. Redzic ZB, Isakovic AJ, Misirlic Denci.c ST, Popadic D, Segal MB: Uneven
distribution of nucleoside transporters and intracellular enzymatic
degradation prevent transport of intact [14C] adenosine across the
sheep choroid plexus epithelium as a monolayer in primary culture.
Cerebrospinal Fluid Res 2006, 3:4.
35. Redzic ZB, Biringer J, Barnes K, Baldwin SA, Al-Sarraf H, Nicola PA, Young JD,
Cass CE, Barrand MA, Hladky SB: Polarized distribution of nucleoside
transporters in rat brain endothelial and choroid plexus epithelial cells.
J Neurochem 2005, 94(5):1420–1426.
doi:10.1186/2045-8118-10-10
Cite this article as: Redzic: Studies on the human choroid plexus
in vitro. Fluids and Barriers of the CNS 2013 10:10.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Redzic Fluids and Barriers of the CNS 2013, 10:10 Page 7 of 7
http://www.fluidsbarrierscns.com/content/10/1/10
